Mizuho Medy Co.,Ltd.

4595

JP3885900005

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-25 am EDT			5-day change	1st Jan Change
3,320 ^JPY	-0.45%		+1.53%	+5.73%

2021	Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index	CI
2020	Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index	CI

Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index

September 23, 2019 at 12:00 am EDT

Latest news about Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index	21-09-20	CI
Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index	20-09-21	CI
Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index	19-09-23	CI
Certain Common Shares of Mizuho Medy Co.,Ltd. are subject to a Lock-Up Agreement Ending on 13-JUN-2016.	16-06-12	CI
Mizuho Medy Co.,Ltd. has completed an IPO in the amount of ¥358.6 million.	15-12-16	CI
Mizuho Medy Co.,Ltd. has filed an IPO.	15-11-12	CI
Shunsuke Matsunaga and MIZUHO MEDY Co.,Ltd. cancelled the acquisition of 33.1% stake in Bio Matrix Research, Inc. from JCR Pharmaceuticals Co., Ltd..	15-09-25	CI
Shunsuke Matsunaga and MIZUHO MEDY Co.,Ltd. agreed to acquire 33.04% stake in Bio Matrix Research, Inc.	14-09-25	CI

MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-09 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Mizuho Medy Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
MIZUHO MEDY CO.,LTD.	+5.73%	205M
BIOMÉRIEUX	-1.09%	12.72B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.53%	7.5B
DIASORIN S.P.A.	+0.45%	5.48B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.37%	4.61B
LANTHEUS HOLDINGS, INC.	+5.16%	4.47B
10X GENOMICS, INC.	-51.93%	3.28B
ANDON HEALTH CO., LTD.	+11.34%	2.71B
VITROLIFE AB	-19.05%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.07%	1.74B

Diagnostic & Testing Substances